Prime Capital Investment Advisors LLC Acquires 580 Shares of Zoetis Inc. (NYSE:ZTS)

Prime Capital Investment Advisors LLC grew its holdings in Zoetis Inc. (NYSE:ZTS) by 1.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 38,518 shares of the company’s stock after acquiring an additional 580 shares during the period. Prime Capital Investment Advisors LLC’s holdings in Zoetis were worth $7,526,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the stock. Sumitomo Mitsui Trust Group Inc. lifted its holdings in shares of Zoetis by 0.7% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,112,662 shares of the company’s stock worth $217,392,000 after acquiring an additional 7,412 shares during the last quarter. GSA Capital Partners LLP purchased a new position in Zoetis during the 3rd quarter worth $2,218,000. Waverton Investment Management Ltd increased its stake in shares of Zoetis by 2.2% during the third quarter. Waverton Investment Management Ltd now owns 312,899 shares of the company’s stock valued at $61,133,000 after buying an additional 6,780 shares during the period. Apollon Wealth Management LLC raised its holdings in shares of Zoetis by 7.7% in the third quarter. Apollon Wealth Management LLC now owns 16,961 shares of the company’s stock valued at $3,314,000 after acquiring an additional 1,211 shares in the last quarter. Finally, Nations Financial Group Inc. IA ADV grew its holdings in Zoetis by 32.4% during the 3rd quarter. Nations Financial Group Inc. IA ADV now owns 12,143 shares of the company’s stock worth $2,373,000 after acquiring an additional 2,971 shares in the last quarter. 92.80% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms recently commented on ZTS. Argus upgraded shares of Zoetis to a “strong-buy” rating in a research note on Friday, August 9th. JPMorgan Chase & Co. lifted their price objective on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. BTIG Research raised their target price on Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research report on Monday, August 12th. Piper Sandler boosted their price target on shares of Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, August 14th. Finally, Stifel Nicolaus lifted their target price on shares of Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a research note on Wednesday, September 18th. Ten equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Zoetis has an average rating of “Buy” and a consensus target price of $221.44.

Zoetis Price Performance

Shares of NYSE ZTS opened at $173.95 on Wednesday. The company’s 50-day moving average price is $188.00 and its 200 day moving average price is $179.93. The stock has a market cap of $78.48 billion, a price-to-earnings ratio of 32.70, a PEG ratio of 2.70 and a beta of 0.90. The company has a current ratio of 3.69, a quick ratio of 2.27 and a debt-to-equity ratio of 1.26. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $201.92.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.46 by $0.12. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The firm had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.29 billion. During the same period last year, the company earned $1.36 EPS. The firm’s quarterly revenue was up 11.6% on a year-over-year basis. As a group, research analysts forecast that Zoetis Inc. will post 5.9 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 3rd. Stockholders of record on Thursday, October 31st will be given a dividend of $0.432 per share. The ex-dividend date is Thursday, October 31st. This represents a $1.73 annualized dividend and a dividend yield of 0.99%. Zoetis’s dividend payout ratio is presently 32.52%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.